MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 12-23-2023
Natus Medical Incorporated Total Non Current Liabilities 2011-2026 | NTUS
Annual Total Non Current Liabilities Natus Medical Incorporated
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 43.5 M | 63.6 M | 106 M | 196 M | 152 M | 11.7 M | 13 M | 40 M | 24.5 M | 15.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 196 M | 11.7 M | 66.6 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 13.14 | 0.23 % | $ 1.78 B |  USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 10.69 | 2.99 % | $ 383 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 26.13 | 1.04 % | $ 221 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.36 | 1.05 % | $ 126 M |  France |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 11.21 | 0.22 % | $ 317 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 2.09 | 2.21 % | $ 1.27 M | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 56.54 | 0.76 % | $ 1.66 B | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.63 | 2.87 % | $ 39.2 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 60.35 | 0.42 % | $ 3.29 B |  Britain |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.08 | 4.37 % | $ 18.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 15.26 | 1.29 % | $ 358 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 90.84 | 0.7 % | $ 12.3 B | USA |
 |
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 37.36 | 1.77 % | $ 1.16 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.02 B | $ 87.13 | -1.61 % | $ 3.03 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 83.61 | 0.1 % | $ 48.9 B | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.08 | 0.2 % | $ 5.77 M | USA |
 |
Stryker Corporation
SYK
|
13 B | $ 304.09 | -3.48 % | $ 116 B | USA |
 |
TransMedics Group
TMDX
|
34.5 M | $ 100.78 | -0.01 % | $ 3.43 B | USA |
 |
LENSAR
LNSR
|
3.44 M | $ 5.21 | -0.38 % | $ 62.3 M | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 19.81 | 1.46 % | $ 1.35 B | USA |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 1.33 | 3.91 % | $ 54.1 M | USA |
 |
MiMedx Group
MDXG
|
65.4 M | $ 3.58 | 6.55 % | $ 529 M | USA |
 |
Myomo
MYO
|
275 K | $ 0.87 | 1.21 % | $ 36.4 M | USA |